Breathing News and Research

RSS

Researchers treat common elastic bands with graphene to create flexible sensor for medical use

Although body motion sensors already exist in different forms, they have not been widely used due to their complexity and cost of production.

20 Aug 2014

New therapeutic drug may prevent respiratory depression in patients taking opioid medication

People taking prescription opioids to treat moderate to severe pain may be able to breathe a little easier, literally.

20 Aug 2014

Hatha yoga improves sedentary older adults' cognitive performance

Practicing hatha yoga three times a week for eight weeks improved sedentary older adults' performance on cognitive tasks that are relevant to everyday life, researchers report.

19 Aug 2014

Researchers use new gene editing method to correct mutation that leads to DMD

UT Southwestern Medical Center researchers successfully used a new gene editing method to correct the mutation that leads to Duchenne muscular dystrophy (DMD) in a mouse model of the condition.

17 Aug 2014

UI scientists discover that CF mucus abnormality is present at birth

Mucus is key to keeping our lungs clean and clear of bacteria, viruses, and other foreign particles that can cause infection and inflammation. When we inhale microbes and dust, they are trapped in the mucus and then swept up and out of the lungs via a process called mucociliary transport.

16 Aug 2014

UH Case Medical Center offers new FDA-approved treatment for obstructive sleep apnea

University Hospitals Case Medical Center is the first in Ohio and among the first in the United States to begin offering a new FDA-approved treatment for obstructive sleep apnea (OSA).

16 Aug 2014

Combination of NASBA and real-time qPCR detects aspergillosis with 100% accuracy

The fungal infection invasive aspergillosis (IA) can be life threatening, especially in patients whose immune systems are weakened by chemotherapy or immunosuppressive drugs. Despite the critical need for early detection, IA remains difficult to diagnose.

14 Aug 2014

Health institutions tackle high rate of preterm birth

An estimated 15 million babies are born preterm every year and more than one million die within the first 30 days after birth.

14 Aug 2014

Dangerous air quality alert issued due to high mold count

A dangerous air quality alert was called today due to the extremely high count for mold detected in the Gottlieb Allergy Count.

13 Aug 2014

Measurement of respiratory rate is underutilized in diagnosis of pneumonia

Pneumonia - a severe lung infection - is the most common disease calling for hospital admission. More than one out of ten pneumonia patients die of the disease.

13 Aug 2014

Scientists use nanowires to monitor and influence cellular activity

No longer just fantastical fodder for sci-fi buffs, cyborg technology is bringing us tangible progress toward real-life electronic skin, prosthetics and ultraflexible circuits.

12 Aug 2014

ResMed releases new forward-thinking connected care solution for SDB treatment

ResMed today announced Air Solutions, a new forward-thinking connected care solution for treating sleep-disordered breathing that can benefit all stakeholders in the care continuum. The ResMed Air Solutions platform has data-driven components that span from diagnosis to treatment, compliance management and patient engagement.

From ResMed Corp 11 Aug 2014

Longer looks: Kentucky is health law poster child; how to negotiate a lower medical bill; the Ebola outbreak up close

About a year ago, on Aug. 22, a team of inspectors from the Centers for Medicare and Medicaid Services (CMS) unit of the U.S. Department of Health and Human Services arrived in Frankfort, Ky., to see if the people working out of a nondescript warehouse there were going to be able to pull off the launch of Kentucky's Obamacare health-insurance exchange.

8 Aug 2014

New lifesaving product aims at reducing death toll from heroin abuse

A new, lifesaving product aimed at reducing the death toll from heroin abuse — developed by a professor at the University of Kentucky College of Pharmacy — is in its final round of clinical trials and has received Fast Track designation by the Food and Drug Administration.

7 Aug 2014

Idera collaborates with TMA to advance new potential treatment approach for myositis

Idera Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing nucleic acid therapeutics for patients with cancer and rare diseases, and The Myositis Association (TMA), the only nonprofit organization dedicated to solely serving all patients with inflammatory myopathies, today announced a collaboration to advance a new potential treatment approach for polymyositis and dermatomyositis known as Toll-like receptor (TLR) antagonism.

7 Aug 2014

New tool promises to reduce deaths caused by heroin overdose

A new, lifesaving product aimed at reducing the death toll from heroin abuse - developed by a professor at the University of Kentucky College of Pharmacy - is in its final round of clinical trials and has received Fast Track designation by the Food and Drug Administration.

7 Aug 2014

Cancer fighter may also help patients survive pneumonia

The tip of an immune molecule known for its skill at fighting cancer may also help patients survive pneumonia, scientists report.

5 Aug 2014

Ragweed pollen reported for first time in 2014 allergy reporting season

Later summer triggers ragweed allergies in 10 to 20 percent of Americans and today spells misery for those with sensitive systems. Ragweed pollen was reported for the first time in the 2014 allergy reporting season, causing a pollen vortex of sneezing, itching and headaches for Midwesterners.

5 Aug 2014

Children of immigrants are 3 times as likely to have lower levels of physical activity

Immigrant children from all racial and ethnic backgrounds are more likely to be sedentary than U.S.-born white children, according to a new study by sociologists at Rice University.

5 Aug 2014

Neuralstem doses final patient with NSI-566 stem cells in Phase II trial

Neuralstem, Inc. announced that the final patient was treated in its Phase II trial using NSI-566 spinal cord-derived neural stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).

4 Aug 2014